---
title: "ADRA2B"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Gene Information Analysis Report: ADRA2B"
tags: ['ADRA2B', 'Alpha2AdrenergicReceptor', 'Neurotransmitters', 'AnxietyDisorders', 'DrugResponse', 'TherapeuticStrategies', 'MissenseMutation', 'SomaticSNVs']
---

# Gene Information Analysis Report: ADRA2B

## Description
The ADRA2B gene is located on chromosome 2 (2p13) and is responsible for encoding the alpha-2B adrenergic receptor. This receptor interacts with different neurotransmitters such as norepinephrine and epinephrine and modulates various physiological and pathological processes.

## Function of the gene
The ADRA2B gene is involved in the regulation of different metabolic processes, including blood pressure control, modulation of insulin secretion, platelet function, and the sympathetic nervous system. This gene is also implicated in the regulation of behavioral responses such as the response to stress, anxiety, and depression.

## External IDs and Aliases
- HGNC ID: 294
- NCBI Entrez Gene ID: 150
- Ensembl Gene ID: ENSG00000151682
- OMIM ID: 104221
- UniProtKB/Swiss-Prot ID: P18089
- Aliases: ADR2, ADRB2RL1, ADRB2R3

## Mutations
- AA Mutation List:

| Mutation | Mutation Type | dbSNP ID |
|----------|---------------|----------|
| p.Pro68Leu | Missense | rs1800888 |
| p.Ile405Val | Missense | rs1042714 |

- Somatic SNVs/InDels:
Not available in current resources

## Related Diseases
The ADRA2B gene has been associated with various diseases, including:

- Anxiety Disorders
- Schizophrenia
- Depression
- Bipolar Disorder
- Attention Deficit Hyperactivity Disorder (ADHD)
- Alcohol Dependence
- Substance Abuse

## Treatment and Prognosis
Since ADRA2B gene activity is associated with different pathologies, therapeutic strategies aimed at modulating this gene activity have been developed. Some drugs that specifically target the alpha-2B adrenergic receptor are clonidine and guanfacine. These drugs can be used to treat hypertension, attention deficit hyperactivity disorder and also have potential application in substance abuse disorders.

## Drug Response
Individuals vary in their response to medication targeted at the alpha-2B adrenergic receptor. Variations in the ADRA2B gene could be associated with the differences in response to medication. In particular, the variation rs1800888 has been associated with a reduced response to clonidine in treating hypertension.

## References
- Bart G. (2012). Alpha-2 Adrenergic Agonists for the Treatment of Opioid Use Disorder. CNS Drugs, 26, 451–465. [Click](https://doi.org/10.2165/11632870-000000000-00000)
- Erhardt A., Czibere L., Roeske D., Lucae S., Unschuld P.G., Ripke S., Specht M., Kohli M.A., Kloiber S., Ising M., Heck A., Pfister H., Zimmermann P., Lieb R., Holsboer F., & Müller-Myhsok B. (2011). TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry, 16(6), 647–663. [Click](https://doi.org/10.1038/mp.2010.57)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**